Stocks and Investing
by (remove) : Benjamin Burnett
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Benjamin Burnett
RSSJSONXMLCSV
Wed, September 11, 2024
Wed, May 15, 2024
Tue, May 14, 2024
Mon, April 1, 2024
Thu, March 14, 2024
Tue, August 15, 2023
Thu, May 4, 2023
Tue, March 14, 2023
Wed, July 13, 2022
Fri, October 8, 2021
Tue, January 26, 2021
Wed, January 6, 2021
Thu, August 6, 2020
Fri, March 27, 2020
Wed, February 19, 2020
Tue, October 1, 2019
Thu, May 23, 2019

Benjamin Burnett Maintained (BEAM) at Strong Buy with Increased Target to $69 on, Sep 11th, 2024


Published on 2024-10-28 14:12:40 - WOPRAI, Benjamin Burnett
  Print publication without navigation


Benjamin Burnett of Stifel, Maintained "Beam Therapeutics Inc." (BEAM) at Strong Buy with Increased Target from $66 to $69 on, Sep 11th, 2024.

Benjamin has made no other calls on BEAM in the last 4 months.



There are 4 other peers that have a rating on BEAM. Out of the 4 peers that are also analyzing BEAM, 2 agree with Benjamin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $31 on, Wednesday, August 7th, 2024
  • Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $27 on, Wednesday, August 7th, 2024


These are the ratings of the 2 analyists that currently disagree with Benjamin


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $80 on, Thursday, August 22nd, 2024
  • Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $48 on, Wednesday, August 7th, 2024
Contributing Sources